Lenard A. Adler, MD, discusses the diagnosis of adult attention-deficit/hyperactivity disorder, which remains a clinically challenging entity to diagnose due to similar presentations in other disease...
Jacob Miguel Vigil, PhD, discusses new study findings that suggest THC may confer more therapeutic benefit than CBD across many different health conditions, and why he says now is the “Golden Age” of...
In the final installment of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA discusses suicidality in patients with schizophrenia compared with the general...
Sarah E. Paul and Ryan Bogdan, PhD, from Washington University in St Louis, discuss their recent study on the effects of prenatal cannabis exposure on childhood psychopathology.
In part 3 of his podcast series with Consultant360, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in...
Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to...
Dr Raymond Cho, from Baylor College of Medicine, discusses the upcoming SARDAA conference on schizophrenia and his outlook on mental health in the United States.
In this video, Lenard A. Adler, MD, director of the Adult ADHD program at NYU School of Medicine, discusses the role of primary care doctors in the diagnosis, treatment, and management of adult patients...
